Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

ADVM | Adverum Biotechnologies Inc

Index- P/E- EPS (ttm)-1.33 Insider Own12.61% Shs Outstand100.12M Perf Week-28.14%
Market Cap121.19M Forward P/E- EPS next Y-1.00 Insider Trans0.74% Shs Float88.26M Perf Month-32.58%
Income-133.43M PEG- EPS next Q-0.32 Inst Own56.27% Short Float / Ratio1.52% / 3.24 Perf Quarter-22.08%
Sales3.60M P/S33.66 EPS this Y22.87% Inst Trans0.57% Short Interest1.34M Perf Half Y71.43%
Book/sh1.30 P/B0.92 EPS next Y17.17% ROA-43.30% Target Price4.25 Perf Year20.00%
Cash/sh1.40 P/C0.86 EPS next 5Y- ROE-71.11% 52W Range0.53 - 2.34 Perf YTD107.08%
Dividend- P/FCF- EPS past 5Y-3.90% ROI-67.76% 52W High-48.72% Beta0.75
Dividend %- Quick Ratio3.31 Sales past 5Y-59.46% Gross Margin-276.72% 52W Low125.99% ATR0.14
Employees123 Current Ratio3.31 Sales Q/Q- Oper. Margin-3841.14% RSI (14)30.81 Volatility11.10% 8.84%
OptionableYes Debt/Eq0.69 EPS Q/Q29.25% Profit Margin-3706.47% Rel Volume0.31 Prev Close1.19
ShortableYes LT Debt/Eq0.50 EarningsAug 10 AMC Payout- Avg Volume413.41K Price1.20
Recom1.40 SMA20-24.15% SMA50-30.48% SMA2003.89% Volume129,702 Change0.84%
Date Action Analyst Rating Change Price Target Change
Jul-07-22Upgrade Truist Hold → Buy $4
Jul-23-21Downgrade Cantor Fitzgerald Overweight → Neutral
May-03-21Downgrade SVB Leerink Outperform → Mkt Perform $5
Apr-29-21Downgrade Truist Buy → Hold $30 → $9
Apr-29-21Downgrade RBC Capital Mkts Outperform → Sector Perform $6
Apr-29-21Downgrade Chardan Capital Markets Buy → Neutral $5
Dec-16-20Initiated UBS Neutral $13
Nov-12-20Upgrade Raymond James Underperform → Mkt Perform
Jun-26-20Downgrade Raymond James Mkt Perform → Underperform
May-13-20Initiated RBC Capital Mkts Outperform $24
Sep-26-23 04:05PM
Sep-21-23 04:05PM
Sep-05-23 04:05PM
Aug-21-23 04:05PM
Aug-14-23 08:00AM
04:20PM Loading…
Aug-10-23 04:20PM
Jun-12-23 08:00AM
Jun-02-23 08:00AM
May-25-23 06:30AM
May-18-23 09:00AM
May-11-23 04:47PM
May-10-23 04:05PM
04:30PM Loading…
May-02-23 04:30PM
Apr-23-23 01:00PM
Apr-21-23 06:03AM
Apr-18-23 08:00AM
Apr-17-23 04:05PM
Apr-04-23 09:40AM
Mar-30-23 04:05PM
Mar-02-23 10:23AM
Feb-27-23 04:05PM
Jan-18-23 04:05PM
Dec-06-22 04:05PM
Nov-10-22 04:05PM
Nov-04-22 12:08PM
Oct-27-22 04:05PM
Sep-30-22 04:45PM
04:05PM Loading…
Sep-27-22 04:05PM
Sep-23-22 04:05PM
Sep-15-22 05:19PM
Sep-14-22 08:00AM
Sep-08-22 04:05PM
Aug-26-22 04:05PM
Aug-11-22 04:05PM
Aug-10-22 04:05PM
Aug-01-22 04:05PM
Jul-25-22 07:16AM
Jul-15-22 09:52AM
Jul-08-22 08:00AM
Jul-07-22 05:14PM
Jul-06-22 04:05PM
Jun-24-22 08:00AM
Jun-09-22 08:00AM
Jun-02-22 04:05PM
May-19-22 08:00AM
May-18-22 08:11AM
May-17-22 04:05PM
May-12-22 04:05PM
May-11-22 02:51PM
May-09-22 04:05PM
May-02-22 04:30PM
May-01-22 02:15PM
Apr-19-22 06:00PM
Apr-07-22 02:50PM
Apr-06-22 04:05PM
Mar-29-22 04:05PM
Mar-17-22 04:05PM
Mar-02-22 12:11PM
Feb-28-22 08:00AM
Feb-15-22 04:22AM
Feb-07-22 04:05PM
Jan-06-22 04:05PM
Jan-04-22 08:00AM
Jan-01-22 06:02AM
Dec-21-21 12:42PM
Dec-06-21 09:00AM
Nov-30-21 10:25AM
Nov-17-21 04:51AM
Nov-04-21 04:05PM
Oct-09-21 11:17AM
Oct-05-21 05:17AM
Oct-04-21 02:31PM
Oct-03-21 08:14AM
Oct-01-21 04:00PM
Sep-27-21 09:00AM
Aug-23-21 09:00AM
Aug-19-21 07:05AM
Aug-06-21 10:19AM
Aug-05-21 04:05PM
Jul-22-21 04:05PM
Jul-19-21 02:49PM
Jul-01-21 08:00AM
Jun-28-21 12:00PM
Jun-24-21 04:05PM
Jun-21-21 01:22AM
Jun-07-21 10:00AM
Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Seyedkazemi SetarehChief Development OfficerSep 15Sale1.526,2019,42947,674Sep 18 06:54 PM
Rubinstein Linda MChief Financial OfficerJun 07Buy1.45100,000145,490100,000Jun 09 04:26 PM
Fischer LaurentCEO, President and DirectorMar 15Sale0.7841,23932,232692,141Mar 17 06:01 PM
Soparkar PeterChief Operating OfficerMar 15Sale0.7813,36010,442265,891Mar 17 06:02 PM
Riley BrigitChief Scientific OfficerMar 15Sale0.787,2995,705117,435Mar 17 06:02 PM